Consumer health companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 2 spellings of its name, each linked to the record.
As of Nov 22, 2026, FDA's public records list Agebox with 2 drug recalls and 1 warning letter. The most recent is a warning letter dated Dec 19, 2025: Warning letter: Unapproved new drug, Labeling.
Drug approvals, 510(k) clearances, recalls and letters, 2025 to 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Dec 19, 2025 | Warning letter: Unapproved new drug, LabelingCDER | Warning letter |
| Oct 28, 2025 | Agebox iKids-Growth (Night Formula), 60-count bottles, Manufactured Exclusively For: AGEBOX Inc., Wilmington, DE 19801 USA, UPC 850065597027Class II · Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren | Drug recall |
| Oct 28, 2025 | Agebox iKids-Growth (Day Formula) capsules, 60-count bottles, Manufactured Exclusively For: AGEBOX Inc., Wilmington, DE 19801 USA, UPC 8…Class II · Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren | Drug recall |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.